Similarly, ketamine-induced baseline gamma power increases are also abolished in GluN2D knockout mice.32 These results may suggest that NMDAR antagonists are effective preferentially at GluN2D-containing GABA neurons, leading to schizophrenia-like phenotypes in mice. The gene discussed is GRIN2D; the disease is schizophrenia.